Great Britain
This article was added by the user . TheWorldNews is not responsible for the content of the platform.

Sanofi/GSK/Haleon: The fear of cancer is stomach-churning

Stress causes "ulcers and heartburn," Lex said in FT. “Currently, the treatment of these afflictions is causing investor anxiety.”

Shares of GlaxoSmithKline, Sanofi, and his new GSK spin-off, Haleon, all plunged last week. , lost tens of billions of dollars. Antidote Zantac. Damages, if awarded, could reach $45 billion, according to Morgan Stanley. And since the rights to commercial versions of Zantak have been transferred repeatedly, "it's unclear where the blame lies."

The question of whether Zantac (a brand name for a drug called ranitidine) produces a possible carcinogen called NDMA has been in the background for years,CNBC10} said Julianna Tatelbaum: Although it was officially taken off the shelf in 2020, the legal process has been heartbreaking.The first of more than 2,000 cases began in the United States this month.

Pharmaceutical companies believe they have a strong legal position, Fierce Pharma said. We support the conclusion that there is no increase in Even if that risk is demonstrated, it would be "difficult" to prove that the company "was aware of the danger and failed to warn its customers" before exiting Zantac.

This lawsuit poses a sticky situation for GSK and the recently surfaced Haleon, said Alistair Osborne in The Times. If liability becomes an issue, it could mean that "four weeks ago there was an unsightly legal issue between two of his companies that belonged to the same group."

Precedents suggest investors remain vigilant, Rex said. The story of the Bayer/Roundup herbicide, which ultimately cost German drugmakers at least $16 billion, "shows how easy it is to draw a line under the claims prematurely." 21}